Therapeutic effects of ellagic acid on memory, hippocampus electrophysiology deficits, and elevated TNF-α level in brain due to experimental traumatic brain injury

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 253

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-20-4_008

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

Objective(s): Cognitive defects such as learning and memory impairment are amongst the most repetitious sequelae after sever and moderate traumatic brain injury (TBI). It was suggested that ellagic acid (EA), an innate phenol product, display neuroprotective properties against oxidative and inflammatory damages after brain injury. The object of the current study was therapeutic properties of EA on blood-brain barrier (BBB) interruption and elevated content of TNF-α in brain tissue followed by neurologic aftereffects, cognitive and brain electrophysiology deficits as outcomes of diffuse TBI in rat. Materials and Methods: TBI was induced by a ۲۰۰ g weight falling by a ۲-m height through a free-falling tube onto the head of anesthetized rat. TBI rats treated immediately after trauma with EA             (۱۰۰ mg/kg, IP) once every ۸ hr until ۴۸ hr later. Neurologic outcomes, passive avoidance task (PAT), hippocampal long-term potentiation (LTP), BBB permeability and content of TNF-α in brain tissue were evaluated. Results: TBI induced significant impairments in neurological score, BBB function, PAT and hippocampal LTP in TBI+Veh group in compare with Sham+Veh (P<۰.۰۰۱). EA treatment decreased neurologic severity score (NSS), restored increased BBB permeability, cognitive and hippocampal LTP abnormalities, and elevated brain content of TNF-α due to TBI significantly (P<۰.۰۰۱). Conclusion: Our findings propose that EA can restore NSS, cognitive and LTP deficits and prevent brain inflammation may by restore BBB permeability as well as lowering brain content of TNF-α following TBI.

نویسندگان

Shahram Mashhadizadeh

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd, Ahvaz, Iran

Yaghoub Farbood

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd, Ahvaz, Iran

Mahin Dianat

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd, Ahvaz, Iran

Ali Khodadadi

Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd, Ahvaz, Iran

Alireza Sarkaki

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd, Ahvaz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Al Nimer F, Lindblom R, Ström M, Guerreiro-Cacais AO, Parsa ...
  • ۲.Mathers CD, Loncar D. Projections of global mortality and burden ...
  • ۳.Kalsotra A, Zhao J, Anakk S, Dash PK, Strobel HW. ...
  • ۴.Kumar A, Loane D. Neuroinflammation after traumatic brain injury: opportunities ...
  • ۵.Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood–brain barrier ...
  • ۶.Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, ...
  • ۷.Ribbers GM. Brain Injury: Long term outcome after traumatic brain ...
  • ۸.Newman DJ, Cragg GM. Natural Products as Sources of New ...
  • ۹.Morton LW, Abu-Amsha Caccetta R, Puddey IB, Croft KD. Chemistry ...
  • ۱۰.Ben Nasr C, Ayed N, Metche M. Quantitative determination of ...
  • ۱۱.Kostrzewa RM, Segura-Aguilar J. Novel mechanisms and approaches in the ...
  • ۱۲.Clifford MN, Scalbert A. Ellagitannins–nature, occurrence and dietary burden. J ...
  • ۱۳.Wada L, Ou B. Antioxidant activity and phenolic content of ...
  • ۱۴.Atta-Ur-Rahman F, Ngounou M, Choudhary M, Malik S, Makhmoor T, ...
  • ۱۵.Chen HS, Liu M, Shi LJ, Zhao JL, Zhang CP, ...
  • ۱۶.Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, ...
  • ۱۷.Uzar E, Alp H, Cevik MU, Fırat U, Evliyaoglu O, ...
  • ۱۸.Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. ...
  • ۱۹.Selig DK, Segal MR, Liao D, Malenka RC, Malinow R, ...
  • ۲۰.Baldwin SA, Gibson T, Callihan CT, Sullivan PG, Palmer E, ...
  • ۲۱.Colicos MA, Dixon CE, Dash PK. Delayed, selective neuronal death ...
  • ۲۲.Huh JW, Widing AG, Raghupathi R. Differential effects of injury ...
  • ۲۳.Huh JW, Widing AG, Raghupathi R. Midline brain injury in ...
  • Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-alpha ...
  • ۲۵.Pickering M, Cumiskey D, O'Connor JJ. Actions of TNF‐α on ...
  • ۲۶.Rogerio AP, Fontanari C, Melo MC, Ambrosio SR, Souza GE, ...
  • ۲۷.Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles ...
  • Farbood Y, Sarkaki A, Dianat M, Khodadadi A, Haddad MK, ...
  • ۲۹.Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y. Central and ...
  • Abdul-Wahab RH, Al-Momani WM, Janakat S, Oran SA. Bioavailability of ...
  • ۳۲.Khaksari M, Soltani Z, Shahrokhi N, Moshtaghi G, Asadikaram G. ...
  • ۳۳.Lashgari R, Motamedi F, Asl SZ, Shahidi S, Komaki A. ...
  • ۳۴.Paxinos G, Watson C. The rat brain in stereotaxic coordinates: ...
  • ۳۵.Gureviciene I, Ikonen S, Gurevicius K, Sarkaki A, van Groen ...
  • ۳۶.Sarkaki A, Fathimoghaddam H, Mansouri SMT, Shahrani Korrani M, Farbood ...
  • ۳۷.Sarkaki A, Assaei R, Motamedi F, Badavi M, Pajouhi N. ...
  • ۳۸.Sarkaki A, Khaksari Haddad M, Soltani Z, Shahrokhi N, Mahmoodi ...
  • ۳۹.O'Connor CA, Cernak I, Vink R. Both estrogen and progesterone ...
  • ۴۰.Khaksari M, Mahmmodi R, Shahrokhi N, Shabani M, Joukar S, ...
  • ۴۲.Sternbach GL. The Glasgow coma scale. J Emerg Med ۲۰۰۰; ...
  • ۴۳.Reeves TM, Lyeth BG, Povlishock JT. Long-term potentiation deficits and ...
  • ۴۴.Sanders MJ, Sick TJ, Perez-Pinzon MA, Dietrich WD, Green EJ. ...
  • ۴۵.Chao PC, Hsu CC, Yin MC. Anti-inflammatory and anti-coagulatory activities ...
  • ۴۶.Santello M, Volterra A. TNFα in synaptic function: switching gears. ...
  • ۴۷.Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, ...
  • ۴۸.Kaneko M, Stellwagen D, Malenka RC, Stryker MP. Tumor necrosis ...
  • ۴۹.Baune BT, Wiede F, Braun A, Golledge J, Arolt V, ...
  • ۵۰.Beste C, Baune BT, Falkenstein M, Konrad C. variations in ...
  • ۵۱.Santello M, Bezzi P, Volterra A. TNF-α controls glutamatergic gliotransmission ...
  • ۵۲.McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: ...
  • ۵۳.Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-alpha ...
  • ۵۴.Wyss-CorayT, Mucke L. Inflammation in neurodegenerative disease—a double-edged sword. Neuron ...
  • ۵۵.Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of ...
  • ۵۶.Olmos G, Lladó J. Tumor necrosis factor alpha: A link ...
  • ۵۷.Liu T, Clark R, McDonnell P, Young P, White R, ...
  • ۵۸.Álvarez A, Cacabelos R, Sanpedro C, García-Fantini M, Aleixandre M. ...
  • ۵۹.BabuGN, Kumar A, Chandra R, Puri S, Kalita J, Misra ...
  • ۶۰.Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev ...
  • ۶۱.Wang X, Yue TL, Barone FC, White RF, Gagnon RC, ...
  • ۶۲.Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, ...
  • ۶۳.Golan H, Levav T, Mendelsohn A, Huleihel M. Involvement of ...
  • ۶۴.Yang L, Lindholm K, Konishi Y, Li R, Shen Y. ...
  • ۶۵.Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, ...
  • ۶۶.Butler M, O'connor J, Moynagh P. Dissection of tumor-necrosis factor-α ...
  • ۶۷.Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation ...
  • ۶۸.Floden AM, Li S, Combs CK. β-Amyloid-stimulated microglia induce neuron ...
  • ۶۹.O'Connor JJ, Moynagh PN, Butler MP, Cumiskey D. The inhibitory ...
  • ۷۰.Umesalma S, Sudhandiran G. Differential inhibitory effects of the polyphenol ...
  • ۷۱.Yu YM, Chang WC, Wu CH, Chiang SY. Reduction of ...
  • نمایش کامل مراجع